Bill Doyle has served as Novocure’s Executive Chairman since 2009 and a director since 2004. Mr. Doyle has also been the Managing Director of WFD Ventures LLC, a private venture capital firm he co-founded, since 2002. Prior to 2002, Mr. Doyle was a member of Johnson & Johnson’s Medical Devices and Diagnostics Group Operating Committee and was Vice President, Licensing and Acquisitions. While at Johnson & Johnson, Mr. Doyle was also chairman of the Medical Devices Research and Development Council, Worldwide President of Biosense-Webster, Inc. and a member of the boards of Cordis Corporation and Johnson & Johnson Development Corporation, Johnson & Johnson’s venture capital subsidiary. From 1992 to 1995, Mr. Doyle was a management consultant in the healthcare group of McKinsey & Company. Mr. Doyle holds an S.B. in materials science and engineering from the Massachusetts Institute of Technology and an M.B.A. from Harvard Business School. Mr. Doyle serves on Harvard Business School’s Board of Dean’s Advisors, MIT’s Institute of Medical Engineering & Science Visiting Committee, and the Cold Spring Harbor Laboratory Technology Innovation Partnership Committee for commercialization of research. Mr. Doyle, previously a member of the investment team at Pershing Square Capital Management L.P., a private investment firm, also serves on the Pershing Square Sohn Cancer Research Prize Governing Board.